Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of epinephrine, norepinephrine and phenylephrine on intraoperative hemodynamics
2024-517373-25-00Phase 4Authorised
- Sponsor
- Medical University of Vienna
- Start
- Oct 2024
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of orphenadrine, epinephrine and norepinephrine (3 arms), sponsored by Medical University of Vienna. Primary endpoint: Time weighted average cardiac output. Planned start Oct 2024; status: authorised.
02
Drugs
orphenadrineepinephrinenorepinephrine
Beyond the preview
Go deeper on 2024-517373-25-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-517373-25-00.